Last update 16 May 2025

Esuberaprost Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
E-beraprost sodium, Esuberaprost, Esuberaprost potassium
+ [8]
Action
agonists
Mechanism
PGI2 receptor agonists(Prostanoid IP receptor agonists)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H30NaO5
InChIKeyLJCCZMFYFWMMDN-ZTWNIFTGSA-N
CAS Registry152695-53-9

External Link

KEGGWikiATCDrug Bank
D10703---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Occlusion of artery
South Korea
17 Jan 1994
Pulmonary Arterial Hypertension
South Korea
17 Jan 1994
Ulcer
South Korea
17 Jan 1994
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glomerular diseasePhase 2-01 Oct 2005
Kidney Failure, ChronicPhase 2-01 Oct 2005
NephrosclerosisPhase 2-01 Oct 2005
NeoplasmsPhase 1
United States
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
112
(Esuberaprost)
qjeyckzjiz = spdwhvrwrp rmwptnprqs (fskzysaotn, dyktcnsfsv - idiehbthuh)
-
07 Sep 2020
Placebo+Esuberaprost
(Placebo/Esuberaprost)
qjeyckzjiz = zxesqyuwwq rmwptnprqs (fskzysaotn, oeyrggkpym - aosypekxbu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free